346 related articles for article (PubMed ID: 21412813)
1. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway.
Wu H; Jin M; Han D; Zhou M; Mei X; Guan Y; Liu C
Biochem Biophys Res Commun; 2015 Mar; 458(4):862-8. PubMed ID: 25701781
[TBL] [Abstract][Full Text] [Related]
3. Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic β cells and liver.
Wang C; Burkhardt BR; Guan Y; Yang J
Nutr Rev; 2012 Feb; 70(2):100-6. PubMed ID: 22300596
[TBL] [Abstract][Full Text] [Related]
4. FAM3B (PANDER) functions as a co-activator of FOXO1 to promote gluconeogenesis in hepatocytes.
Chi Y; Meng Y; Wang J; Yang W; Wu Z; Li M; Wang D; Gao F; Geng B; Tie L; Zhang W; Yang J
J Cell Mol Med; 2019 Mar; 23(3):1746-1758. PubMed ID: 30488666
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
6. FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis.
Wang C; Chi Y; Li J; Miao Y; Li S; Su W; Jia S; Chen Z; Du S; Zhang X; Zhou Y; Wu W; Zhu M; Wang Z; Yang H; Xu G; Wang S; Yang J; Guan Y
Hepatology; 2014 May; 59(5):1779-90. PubMed ID: 24806753
[TBL] [Abstract][Full Text] [Related]
7. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
8. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
[TBL] [Abstract][Full Text] [Related]
9. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
[TBL] [Abstract][Full Text] [Related]
11. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
13. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1.
Guo H; Xia M; Zou T; Ling W; Zhong R; Zhang W
J Nutr Biochem; 2012 Apr; 23(4):349-60. PubMed ID: 21543211
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
[TBL] [Abstract][Full Text] [Related]
15. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
[TBL] [Abstract][Full Text] [Related]
16. Hepatic overexpression of ATP synthase β subunit activates PI3K/Akt pathway to ameliorate hyperglycemia of diabetic mice.
Wang C; Chen Z; Li S; Zhang Y; Jia S; Li J; Chi Y; Miao Y; Guan Y; Yang J
Diabetes; 2014 Mar; 63(3):947-59. PubMed ID: 24296716
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
[TBL] [Abstract][Full Text] [Related]
18. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
[TBL] [Abstract][Full Text] [Related]
19. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
Valenti L; Rametta R; Dongiovanni P; Maggioni M; Fracanzani AL; Zappa M; Lattuada E; Roviaro G; Fargion S
Diabetes; 2008 May; 57(5):1355-62. PubMed ID: 18316359
[TBL] [Abstract][Full Text] [Related]
20. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
Sajan MP; Ivey RA; Lee MC; Farese RV
J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
